Stifel Financial’s Cytosorbents Corp CTSO Stock Holding History

Stifel Financial’s Portfolio CTSO Stock Details CTSO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$27.2K	Hold	48,000	–	–	﹤0.01%	3602
2025 Q4	$30.7K	Hold	48,000	–	–	﹤0.01%	3548
2025 Q3	$44.8K	Hold	48,000	–	–	﹤0.01%	3493
2025 Q2	$61.4K	Hold	48,000	–	–	﹤0.01%	3403
2025 Q1	$48K	Hold	48,000	–	–	﹤0.01%	3357
2024 Q4	$43.7K	Buy	48,000 +3,000	+7%	+$2.94K	﹤0.01%	3322
2024 Q3	$67.5K	Hold	45,000	–	–	﹤0.01%	3286
2024 Q2	$31.6K	Hold	45,000	–	–	﹤0.01%	3307
2024 Q1	$42.8K	Hold	45,000	–	–	﹤0.01%	3265
2023 Q4	$50K	Buy	+45,000	New	+$66.8K	﹤0.01%	3227
2022 Q2	–	Sell	-13,585	Closed	-$43K	–	3347
2022 Q1	$43K	Hold	13,585	–	–	﹤0.01%	3318
2021 Q4	$57K	Sell	13,585 -10,040	-42%	-$56.3K	﹤0.01%	3302
2021 Q3	$192K	Hold	23,625	–	–	﹤0.01%	3144
2021 Q2	$178K	Hold	23,625	–	–	﹤0.01%	3154
2021 Q1	$205K	Buy	23,625 +6,800	+40%	+$64.8K	﹤0.01%	3006
2020 Q4	$134K	Hold	16,825	–	–	﹤0.01%	2907
2020 Q3	$134K	Hold	16,825	–	–	﹤0.01%	2709
2020 Q2	$167K	Buy	+16,825	New	+$155K	﹤0.01%	2626

Other funds holding CTSO

Avenir Corporation Alexandria, Virginia $820M AUM 2.4% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Skylands Capital Milwaukee, Wisconsin $763M AUM 26.49% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SIG

Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return

Pathstone Holdings Englewood, New Jersey $25.1B AUM 22.95% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Stifel Financial's CTSO Position: Q1 2026 in Review

Stifel Financial held its Cytosorbents Corp (CTSO) position steady in Q1 2026 at 48,000 shares worth $27.2K. The position accounts for ﹤0.01% of the portfolio, ranked #3602.

Stifel Financial first reported a position in CTSO in Q2 2020 and has held it in 18 quarters since. The position peaked at $205K in Q1 2021. 50 funds tracked by Wall St. Rank hold CTSO as of Q1 2026.

Stifel Financial held 48,000 shares of Cytosorbents Corp worth $27.2K as of Q1 2026.
Stifel Financial left its Cytosorbents Corp share count unchanged in Q1 2026.
Cytosorbents Corp made up ﹤0.01% of Stifel Financial's portfolio in Q1 2026, its #3602 holding.
Stifel Financial first reported a position in Cytosorbents Corp in Q2 2020 and has held it in 18 quarters since.
Stifel Financial's Cytosorbents Corp position peaked at $205K in Q1 2021.
50 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q1 2026.

Based on Stifel Financial's 13F filing for Q1 2026, filed 12 May 2026.